Search - tctmd.com

Displaying 461 - 480 of 585

Sort: Relevancy | Date

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

August 14, 2012

News Daily News

Se Publica el RIFLE-STEACS: La PCI Transradial Reduce la Mortalidad en Pacientes que han sufrido un STEMI

Jason Kahn

August 03, 2012

News Daily News

RIFLE-STEACS Published: Transradial PCI Lowers Mortality in STEMI Patients

Jason Kahn

August 03, 2012

News Daily News

Subestudio PLATO: ‘La Paradoja del Fumador’ No Revela Efecto Alguno sobre el Ticagrelor

August 03, 2012

News Daily News

PLATO Substudy: ‘Smoker’s Paradox’ Shows No Effect on Ticagrelor

August 03, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Industry News

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

July 05, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

July 03, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Industry News

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

June 26, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

Advertisement

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

Se Publica el RIFLE-STEACS: La PCI Transradial Reduce la Mortalidad en Pacientes que han sufrido un STEMI

RIFLE-STEACS Published: Transradial PCI Lowers Mortality in STEMI Patients

Subestudio PLATO: ‘La Paradoja del Fumador’ No Revela Efecto Alguno sobre el Ticagrelor

PLATO Substudy: ‘Smoker’s Paradox’ Shows No Effect on Ticagrelor

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content